Clinical Trial Details
| Trial ID: | L2987 |
| Source ID: | NCT02694289 |
| Associated Drug: | Metformin |
| Title: | Effects of Metformin in Heart Failure Patients |
| Acronym: | |
| Status: | WITHDRAWN |
| Study Results: | NO |
| Results: | |
| Conditions: | Type 2 Diabetes Mellitus |
| Interventions: | DRUG: Metformin|DRUG: Subcutaneous (sliding scale) Insulin |
| Outcome Measures: | Primary: Units of Insulin used, doses and amounts on insulin needed, from time of hospital admission to hospital discharge, up to one year | Secondary: Blood glucose levels, patient's glycemic control will be evaluated based on blood glucose levels, from time of hospital admission to hospital discharge, up to one year|Length of stay, time from hospital admission to hospital discharge, up to one year|Lactate levels, mmol/L, from time of hospital admission to hospital discharge, up to one year|pro-BNP levels, pg/mL, from time of hospital admission to hospital discharge, up to one year |
| Sponsor/Collaborators: | Sponsor: Maya Guglin |
| Gender: | ALL |
| Age: | ADULT, OLDER_ADULT |
| Phases: | |
| Enrollment: | 0 |
| Study Type: | INTERVENTIONAL |
| Study Designs: | Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT |
| Start Date: | 2016-11 |
| Completion Date: | 2018-09-10 |
| Results First Posted: | |
| Last Update Posted: | 2018-11-23 |
| Locations: | |
| URL: | https://clinicaltrials.gov/show/NCT02694289 |
